Haploscleridamine, a molecule isolated from a sponge of the order Haplosclerida, is a member of a group of natural products that selectively inhibits the E1 ubiquitin pathway and thus shows promise as an anti-cancer drug. We report the development of a reliable synthetic route to Haploscleridamine.
